ctrl K

Watchlist Price Alert

Allogene Therapeutics Inc... (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

1.09

-0.02 (-1.80%)

At close: May 22, 2025, 3:59 PM

1.09

-0.45%

After-hours: May 22, 2025, 07:33 PM EDT

Allogene Therapeutics Revenue Breakdown

Period Ending	Dec 31, 2024
License Revenue	4.6M
License Revenue Growth	n/a

Operating Expense Breakdown

Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019	Dec 31, 2018	Sep 30, 2018	Jun 30, 2018	Mar 31, 2018	Dec 31, 2017
Selling, General, and Administrative Revenue	14.99M	15.52M	16.33M	16.09M	17.27M	17.22M	17.04M	18.52M	18.88M	21M	18.9M	19.51M	19.9M	19.96M	19M	18.78M	16.36M	17.13M	16.62M	15.86M	15.64M	15.21M	15.02M	14.19M	13.06M	14.54M	11.32M	12.53M	2.6M	2K
Selling, General, and Administrative Revenue Growth	-3.40%	-4.99%	+1.53%	-6.83%	+0.25%	+1.07%	-8.01%	-1.91%	-10.08%	+11.14%	-3.14%	-1.95%	-0.32%	+5.06%	+1.15%	+14.79%	-4.50%	+3.10%	+4.77%	+1.41%	+2.82%	+1.31%	+5.84%	+8.65%	-10.20%	+28.50%	-9.65%	+382.33%	+129750.00%	n/a
Research and Development Revenue	50.2M	44.97M	44.71M	50.35M	52.26M	54.66M	45.98M	62.04M	80.24M	75.42M	63.64M	57.17M	60.16M	53.98M	58.72M	52.29M	55.18M	52.23M	51.42M	47.3M	42.04M	49.36M	39.99M	31.77M	23.4M	18.5M	10.87M	122.49M	n/a	n/a
Research and Development Revenue Growth	+11.63%	+0.58%	-11.20%	-3.64%	-4.39%	+18.89%	-25.89%	-22.68%	+6.39%	+18.51%	+11.32%	-4.96%	+11.44%	-8.07%	+12.30%	-5.24%	+5.66%	+1.57%	+8.72%	+12.50%	-14.83%	+23.42%	+25.87%	+35.77%	+26.48%	+70.23%	-91.13%	n/a	n/a	n/a